Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print          Annual reports

Monday 20 September, 2021

GlaxoSmithKline PLC

Director Declaration

RNS Number : 3494M
GlaxoSmithKline PLC
20 September 2021
 

GlaxoSmithKline plc

 

Director Declaration

 

GlaxoSmithKline plc announces, pursuant to the Financial Conduct Authority's Listing Rule 9.6.14(2), that Dr Vivienne Cox CBE, Non-Executive Director, has been appointed as a non-executive director and Chair-designate of Victrex plc with effect from 1 December 2021 and 1 January 2022 respectively. Dr Cox will assume responsibility as Chair of Victrex plc with effect from 11 February 2022. 

 

 

 

V A Whyte

Company Secretary

 

20 September 2021

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNEADNEALEFEFA

a d v e r t i s e m e n t